Register
Question 1
What is the cell concentration in solution three, when combining solution one and solution two?
Correct Answer:
3.4 x 106 cells/ml
Explanation:
To determine the cell concentration in solution three, when combining solutions one and two, it is necessary to perform a calculation that considers the initial concentrations of both solutions along with their respective volumes. The overall concentration in the final solution can be calculated using the formula for mixing two solutions, which involves summing the total number of cells from both solutions and dividing that sum by the total volume of the resulting mixture. If solution one, for example, has a concentration of a certain number of cells per milliliter and solution two has a different concentration, when they are combined, the total number of cells will be the sum of the cells in both solutions. The final volume will also be the total volume of both solutions combined. After performing these calculations accurately, if the result corresponds to 3.4 x 10^6 cells/ml, this confirms that the concentration of cells in solution three is based on correct arithmetic that reflects the distribution and concentration of cells from both incorporated solutions. Therefore, choosing this concentration indicates that the calculation of combined cell numbers and the total resultant volume was executed correctly, leading to the valid conclusion about the concentration of the third solution.
Question 2
How many possible reading frames exist for a eukaryotic DNA sequence of length 200bp that contains an exon of 180bp?
Correct Answer:
6
Explanation:
The correct answer is based on the principle of how reading frames work in nucleic acid sequences. In any given segment of DNA, particularly within a coding region, there are multiple ways to interpret the sequence in terms of potential protein-coding sequences, which is what reading frames represent. For a eukaryotic DNA sequence, the coding region (exon) is read in triplets called codons, and since DNA is double-stranded, each strand can serve as a template for translation. In a single-stranded context, the sequence can be read in three possible frames starting from one of the three nucleotides. Additionally, because a DNA sequence is bi-directional (it can be read from both strands), you can also derive three reading frames from the complementary strand. This results in a total of six reading frames: three from the original strand and three from the reverse complementary strand. In this scenario, you have a 200bp DNA sequence containing an exon of 180bp. While the length of the exon is significant, it does not change the calculation of how many reading frames are created from the entire sequence. Thus, the total possible reading frames for this exon-containing sequence is six, confirming that the understanding of reading frames in
Question 3
Which of the following statements is TRUE regarding chronic rejection?
Correct Answer:
It can involve both antibodies and T cells
Explanation:
Chronic rejection is a complex immunological process that occurs over an extended period, typically months to years after transplantation, rather than immediately after the procedure. The key aspect of chronic rejection is that it is characterized by both the involvement of antibodies and T cells, leading to progressive damage to the transplanted tissue. While T cells play a significant role, chronic rejection is particularly noted for the involvement of antibodies that target the graft. This antibody-mediated component often contributes to the gradual deterioration of the graft function. Hence, stating that chronic rejection can involve both antibodies and T cells accurately highlights the multi-faceted nature of the immune response during this phase of rejection. This contrasts with other statements that suggest conditions and mechanisms not typically associated with chronic rejection. For example, chronic rejection does not occur within days of transplantation, as that's more characteristic of acute rejection, and it is not limited to kidney transplants, as chronic rejection can affect any type of transplanted organ.
Question 4
Which sample is preferred for molecular testing of class II HLA antigens?
Correct Answer:
2ml peripheral blood in EDTA
Explanation:
The preferred sample for molecular testing of class II HLA antigens is peripheral blood in EDTA. This choice is favored primarily because EDTA acts as an anticoagulant, preventing blood from clotting and thus preserving the integrity of the leukocytes in the sample. When testing for HLA class II antigens, functional and genomic analysis requires intact lymphocytes. Peripheral blood, when collected with EDTA, maintains the cells in a state suitable for molecular assays, such as PCR or sequencing. The leukocytes can readily be isolated from the whole blood for further genetic analysis. Moreover, using peripheral blood minimizes the need for complex processing or manipulation that might compromise cell viability or DNA integrity. The use of EDTA ensures that the blood remains in a liquid state, which allows for optimal cellular handling. Other methods of sample preparation, like Ficoll separation or transformed B cell lines, may introduce variables that are less desirable for molecular testing or may not represent the natural population of HLA class II antigens in an individual's immune system as effectively.
Question 5
According to ASHI standards (2005), which information MUST be included on an HLA typing report?
Correct Answer:
The laboratory's address
Explanation:
The inclusion of the laboratory's address on an HLA typing report is essential for several reasons. It provides a clear point of contact for the results and verifies the legitimacy of the report. This transparency ensures that healthcare providers and patients can confirm the origin of the results, allowing for proper follow-up or consultation if necessary. The laboratory's address also contributes to the traceability of the report, which can be critical in the context of clinical care, especially when dealing with transplant patients who require precise HLA matching. While the other options may contain relevant information, they do not carry the same requirement as stipulated by ASHI standards. The names of all directors and supervisors, while important for quality assurance, do not need to be included for the report's validity. The IMGT library used for allele assignments is valuable for technical reproducibility, but not mandated by these standards. Lastly, a patient's diagnosed disease state can be pertinent for clinical context but is not a mandatory component for reporting HLA typing results as per ASHI.
Question 1
Exam overview

About this Exam

The CHS certification exam is typically administered through professional testing centers, most notably Pearson VUE. These proctored centers are located globally and offer a secure and standardized environment for the examination.

Candidates must first apply through ACHI and receive eligibility authorization. Once approved, you will be directed on how to schedule your examination appointment directly with Pearson VUE at a location convenient for you.


More details

Additional Information

Job Opportunities from the Course

Earning the Certified Histocompatibility Specialist designation significantly enhances your professional standing and opens doors to leadership roles within the specialized field of transplant immunology. The dedication and expertise validated by this certification are highly valued by transplant centers and reference laboratories.

The career paths and specific job titles unlocked by this certification include:

  • Histocompatibility Specialist / HLA Laboratory Specialist
  • Lead HLA Technologist / Senior Histocompatibility Technologist
  • Transplant Laboratory Supervisor / Manager
  • Clinical Transplant Coordinator
  • Histocompatibility Director (often requires further advanced degrees, but CHS is a critical step)
  • Quality Assurance Specialist / Coordinator in a Transplant Laboratory
  • Research Specialist in Transplant Immunology

Achieving this certification demonstrates a commitment to excellence and positions you as a recognized expert in ensuring the best possible outcomes for transplant patients.Here is the SEO-optimized study guide for the Certified Histocompatibility Specialist exam, followed by an optimized title and header image.

Certified Histocompatibility Specialist Practice Test

Description

The Certified Histocompatibility Specialist (CHS) credential, offered by the American College of Histocompatibility and Immunogenetics (ACHI), is a premier certification for medical laboratory professionals specializing in the complex field of transplant immunology.

This advanced designation is designed for individuals working in HLA (Human Leukocyte Antigen) laboratories who possess significant experience and a deep understanding of the histocompatibility testing required for solid organ and hematopoietic stem cell transplantation.

Achieving CHS certification validates your expertise, demonstrating that you have the advanced knowledge and skills necessary to ensure safe and compatible transplants, making you a vital part of the transplant team.

 

What the Course Entails and Exam Details

Preparing for the CHS exam involves mastering a broad and deep syllabus encompassing both theoretical knowledge and practical applications in a histocompatibility setting.

The core content areas covered in the examination include:

  • HLA System Genetics and Biology: In-depth knowledge of the major histocompatibility complex (MHC), HLA gene structure, nomenclature, and inheritance patterns.
  • Molecular HLA Typing Techniques: Mastery of technologies such as Sequence-Specific Priming (SSP), Sequence-Specific Oligonucleotide Probe (SSOP) hybridization, and Next-Generation Sequencing (NGS) for defining HLA alleles.
  • Antibody Detection and Identification: Understanding methods like Luminex-based bead assays, flow cytometry crossmatching (FCXM), and virtual crossmatching to identify patient antibodies against HLA.
  • Transplantation Immunology: Comprehensive knowledge of the immune response to transplantation, including rejection mechanisms (cellular and humoral) and immunosuppression strategies.
  • Quality Assurance and Regulatory Compliance: Familiarity with laboratory regulations (e.g., CLIA, ASHI standards), proficiency testing, equipment validation, and standard operating procedures specific to histocompatibility testing.

 

What to Expect in the Final Exam

The CHS examination is a rigorous assessment administered via computer-based testing. It is designed to evaluate not only recitative knowledge but also critical thinking and problem-solving skills in clinical scenarios.

  • Format: The exam consists of multiple-choice questions. These questions range from direct knowledge recall to complex case-study interpretations where you must apply your expertise to clinical situations.
  • Time Limit: Candidates are typically given a substantial timeframe, often around four hours, to complete the examination.
  • Passing Score: The passing score is determined by ACHI using statistical methods to ensure standard competency. It is crucial to refer to the official ACHI Candidate Handbook for the most current information regarding scoring policies and the required passing grade.
  • Specific Rules: Standard testing protocols apply. No outside materials, study guides, or electronic devices are permitted in the testing center. Candidates must present valid identification and arrive scheduled for their appointment.

 

How to Study and Exam Centers

Preparation for the CHS exam must be disciplined and comprehensive, given the depth of knowledge required.

Actionable Study Strategies:

Utilize the ACHI Candidate Handbook: This is your primary resource. Thoroughly review the exam content outline and recommended reference lists

Create a Structured Study Plan: Break down the core content areas and allocate specific study times for each. Dedicate more time to complex subjects like immunogenetics or NGS data interpretation.

Deep Dive into Reference Textbooks: Rely heavily on authoritative texts such as the "ASHI Laboratory Manual" and advanced immunology textbooks. Take detailed notes and create summary sheets for key concepts.

Practice with Sample Questions: While official full-length practice tests may be limited, utilize any sample questions available from ACHI. Form study groups with colleagues to review case studies and practice interpreting complex crossmatch or typing results.

Review Laboratory Protocols: Connect theoretical knowledge with clinical practice. Review your own laboratory’s standard operating procedures (SOPs), quality control logs, and troubleshooting guides, as the exam frequently assesses practical application.

 

Exam Center Information:

The CHS certification exam is typically administered through professional testing centers, most notably Pearson VUE. These proctored centers are located globally and offer a secure and standardized environment for the examination.

Candidates must first apply through ACHI and receive eligibility authorization. Once approved, you will be directed on how to schedule your examination appointment directly with Pearson VUE at a location convenient for you.

 

 

Job Opportunities from the Course

Earning the Certified Histocompatibility Specialist designation significantly enhances your professional standing and opens doors to leadership roles within the specialized field of transplant immunology.

The dedication and expertise validated by this certification are highly valued by transplant centers and reference laboratories.

The career paths and specific job titles unlocked by this certification include:

  • Histocompatibility Specialist / HLA Laboratory Specialist
  • Lead HLA Technologist / Senior Histocompatibility Technologist
  • Transplant Laboratory Supervisor / Manager
  • Clinical Transplant Coordinator
  • Histocompatibility Director (often requires further advanced degrees, but CHS is a critical step)
  • Quality Assurance Specialist / Coordinator in a Transplant Laboratory
  • Research Specialist in Transplant Immunology
Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

ISC2 Certified in Cybersecurity Practice Exam

0 min

Arizona CNA Certified Nursing Assistant Practice Exam

0 min

Certified Professional Public Buyer (CPPB) Practice Exam

0 min

Certified Specialist Business Intelligence (CSBI) Practice Test

0 min

Certified Specialist In Renal Nutrition (CSR) Practice Exam

0 min

Certified Specialist Physician Practice Management (CSPPM) Practice Exam

0 min